Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2025 Earnings Call Transcript February 24, 2026
Day One Biopharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.17.
Operator: Hello, ladies and gentlemen. Welcome to the Day One Biopharmaceuticals, Inc. Fourth Quarter and Full Year 2025 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode. Please be advised that this conference call is...
